Professor Wiberg has nearly 30 years experience in the field of reconstructive surgery with focus on mainly congenital malformations and nerve reconstruction. He has worked scientifically within these areas for nearly 40 years in Uppsala, Umeå and the last 20 years also within UK. He has a wide national and international network both clinically and scientifically. His work and scientific production played an important role when Umeå for the first time got national responsibility (Rikssjukvård) together with Stockholm for major nerve injuries (brachial plexus injuries) . Wiberg is a member since the start of the National Board for Cell, Tissue, Organ and Blood (Nationella Vävnadsrådet) and its subgroup for Celltherapy. He is also a Board Member of the National Board of Health care and Social welfare (Socialstyrelsen) and The Swedish Governments expertgroup for Life Sceince. Prof Wiberg has a total of 125 peer reviewed original articles in Pubmed mainly within the area of nerve reconstructive surgery.
Professor of Hand, Plastic and Reconstructive Surgery
Jagdeep Nanchahal is a surgeon scientist focussing on defining the molecular mechanisms of common diseases and translating his findings through to early phase clinical trials.
He undertook his PhD, funded by the MRC, whilst a medical student in London and led a lab group funded by external grants throughout his surgical training. After completing fellowships in microsurgery and hand surgery in the USA and Australia he was appointed as a senior lecturer at Imperial College. His research interests complement his clinical practice and he first became associated with the Kennedy Institute through his research on patients with rheumatoid arthritis, where his group showed that cytokine inhibition would be effective for controlling tenosynovitis.
His research is now focussed on promoting tissue regeneration by targeting endogenous stem cells and reducing fibrosis. In 2013 his group identified TNF as therapeutic target for Dupuytren’s disease, a common fibrotic condition of the hand. He is currently leading a phase 2b clinical trial funded by the Wellcome Trust and Department of Health to assess the efficacy of local administration of anti-TNF in patients with early stage Dupuytren’s disease. In collaboration with the Structural Genomics Consortium his group are investigating the epigenetic regulation of myofibroblasts in Dupuytren’s disease. His group has also identified a novel mechanism for promoting repair and regeneration of multiple tissues by targeting endogenous stem cells.
He is a proponent of evidence-based medicine and was the only plastic surgery member of the NICE Guidance Development Groups on complex and non-complex fractures. He is co-applicant on a trial led by Prof Matt Costa, Kadoorie Centre, NDORMS, investigating the efficacy of negative pressure wound therapy on closed incisions following orthopaedic trauma.
You can read more here.
Registration is now open for the 2019 meeting via Eventbrite.
Click the image above to be directed through to our registration page.